Wordt geladen...
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT
Grades 2-4 acute graft-versus-host disease (GVHD) occurs in approximately 35% of matched, related donor (MRD) allogeneic hematopoietic cell transplantation (HCT) recipients. We sought to determine if the combination of tacrolimus and sirolimus (Tac/Sir) was more effective than tacrolimus and methotr...
Bewaard in:
Hoofdauteurs: | , , , , , , , , , , , , , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
American Society of Hematology
2014
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4141519/ https://ncbi.nlm.nih.gov/pubmed/24982504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-04-567164 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|